RxDoctor Payments DataLook up a doctor →

Rebecca Johnson, PA

Medical · Spokane, WANPI 1083864045

Payments from drug & device makers

$13,645in general payments, 2019–2025

Across 804 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Amgen$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Novo Nordisk$747
  • GSK$746
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie84$1,401
AstraZeneca66$1,333
Amgen(2 entities)64$1,171
Teva Pharmaceuticals USA, Inc.47$1,112
Novo Nordisk65$747
GSK79$746
Johnson & Johnson36$668
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC45$624
Boehringer Ingelheim32$602
Pfizer35$588
Lilly USA, LLC23$363
Otsuka America Pharmaceutical, Inc.18$338
Abbott16$298
Novartis13$283
Astellas Pharma US Inc17$281
Merck17$278
Medtronic7$263
Exact Sciences11$207
Lundbeck LLC11$187
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$158
Collegium Pharmaceutical, Inc.8$143
Takeda Pharmaceuticals U.S.A., Inc.7$141
Amarin Pharma, Inc.7$111
Bayer7$105
Corcept Therapeutics6$103
Sanofi-aventis U.S. LLC6$98
Boston Scientific3$91
Vanda Pharmaceuticals Inc.5$87
Dexcom, Inc.4$85
Biohaven Pharmaceutical Holding Company Ltd.3$66
Xeris Pharmaceuticals, Inc.3$62
Biohaven Pharmaceuticals, Inc.3$54
Kowa Pharmaceuticals America, Inc.4$54
Avanir Pharmaceuticals, Inc.3$53
Almatica Pharma LLC4$51
Sumitomo Pharma America, Inc.3$51
Eisai Inc.2$47
Gilead2$46
Paratek Pharmaceuticals, Inc.3$46
Grifols USA, LLC2$42
Viiv Healthcare Company1$40
Antares Pharma, Inc.3$39
E.r. Squibb & Sons, L.L.C.2$39
Sanofi Pasteur Inc.2$38
Nevro Corp.1$34
Axsome Therapeutics, Inc.2$31
Kyowa Kirin, Inc.1$30
Impel Pharmaceuticals Inc.1$22
Bardy Diagnostics, Inc.1$21
Ultragenyx Pharmaceutical Inc.1$20
Hologic Sales And Service, LLC1$20
Edwards Lifesciences1$18
Neurocrine Biosciences, Inc.1$16
Radius Health, Inc.1$16
Phathom Pharmaceuticals, Inc.1$15
Corium, LLC1$13
Otsuka Pharmaceutical Development & Commercialization, Inc.1$13
Sanofi1$13
Phadia US Inc.1$13
Therapeuticsmd, Inc.1$12

How this compares

$13,645 in reported general payments places this provider in the 95th percentile of 457 medical providers in Washington.

See all medical providers in Washington →

Medicare billing

Part B allowed, 2024
$64,768
Medicare patients
195
Services billed
1,183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Spokane

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →